RETRACTED: Mechanism of Hyperbaric Oxygen Combined with Astaxanthin Mediating Keap1/Nrf2/HO-1 Pathway to Improve Exercise Fatigue in Mice (Retracted Article)

被引:4
|
作者
Zhang, Zheng [1 ]
Gao, Binghong [2 ]
机构
[1] Shanghai Univ Sport, Sch Kinesiol, Shanghai 200438, Peoples R China
[2] Shanghai Univ Sport, Sch Phys Educ & Sport Training, Shanghai 200030, Peoples R China
关键词
MELATONIN; CAPACITY;
D O I
10.1155/2022/6444747
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective. This work aimed to explore the application and optimization of the electrophysiological monitoring system to real-time monitor the exercise-induced fatigue (EIF) animals and investigate the intervention mechanism of hyperbaric oxygen (HBO) combined with natural astaxanthin (NAX) on EIF. Methods. First, a system was constructed for acquisition, processing, and feature extraction of electrocardiograph (ECG) signal and surface electromyography (EMG) signal for EIF monitoring. The mice were randomly divided into a control group (CG), EIF group (EG), HBO treatment (HBO) group, and HBO combined with NAX treatment (HBO + NAX) group. The effect of the constructed system on classification recognition of EIF was analyzed. The levels of serum antioxidative stress indicators of mice in each group were detected, including malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), glutathione-peroxidation (GSH-Px), and total antioxidant capacity (T-AOC). In addition, the mRNA and protein levels of Keap1/Nrf2/HO-1 pathway related genes in liver tissue were detected. Results. The results showed that the normalized least mean squares algorithm effectively removed the motion artifact interference of ECG signal and can clearly display the signal peak, and high-pass filtering and power frequency filtering effectively removed the motion and baseline drift interference of surface EMG signal. The recognition sensitivity, specificity, and accuracy of the EIF recognition model based on the long- and short-term memory network were 90.0%, 93.3%, and 92.5%, respectively. Compared with the CG, the characteristics of ECG signal and surface EMG signal of the mice in the EIF group changed greatly (P < 0.05); the serum MDA level was increased obviously; the CAT, SOD, GSH, GSH-Px, and T-AOC levels were observably reduced (P < 0.05); the expressions of Keap1 and HO-1 in the liver were reduced remarkably, while the expression of Nrf2 was increased notably (P < 0.05). Compared with the EIF group, the characteristics of ECG signal and surface EMG signal of the mice in the HBO and HBO + NAX groups were obviously improved (P < 0.05); the serum MDA level was significantly reduced; the CAT, SOD, GSH, GSH-Px, and T-AOC levels were greatly increased (P < 0.05); the expressions of Keap1 and HO-1 in the liver were greatly increased, while the expression of Nrf2 was decreased sharply (P < 0.05). Conclusion. Therefore, the feature extraction and classification system of ECG signal combined with surface EMG signal could realize real-time monitoring of EIF status. HBO intervention could improve the body's ability to resist oxidative stress through the Keap1/Nrf2/HO-1 pathway and then improve the EIF state. In addition, the improvement effect of HBO + NAX was more obvious.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] RETRACTED: Preventive Electroacupuncture Alleviates Oxidative Stress and Inflammation via Keap1/Nrf2/HO-1 Pathway in Rats with Cyclophosphamide-Induced Premature Ovarian Insufficiency (Retracted Article)
    Chen, Yang
    Zhao, Rui
    Li, Xiang
    Luan, Yun-peng
    Xing, Li-wei
    Zhang, Xiao-juan
    Wang, Jing
    Xia, Xiao-yan
    Zhao, Rong
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [2] Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1/Nrf2 pathway
    Pan, Yuting
    Li, Weihao
    Feng, Ying
    Xu, Jing
    Cao, Huifang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (02) : 1407 - 1416
  • [3] RETRACTED: Astaxanthin ameliorates cardiomyocyte apoptosis after coronary microembolization by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats (Retracted Article)
    Xue, Yugang
    Sun, Chuang
    Hao, Qimeng
    Cheng, Jin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (03) : 341 - 348
  • [4] Astaxanthin from Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1/Nrf2/HO-1 pathway in mice
    Haotian, Ma
    Chen, Shuaihang
    Xiong, Huaye
    Wang, Meng
    Hang, Wei
    Zhu, Xiaoli
    Zheng, Yubin
    Ge, Baosheng
    Li, Runzhi
    Cui, Hongli
    FOOD & FUNCTION, 2020, 11 (05) : 4659 - 4671
  • [5] Ruscogenin regulates endogenous antioxidation in dopamine neurons by activating Keap1/Nrf2/HO-1 pathway
    Shi, Kai
    Wang, Bing
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (09) : 1779 - 1784
  • [6] RETRACTED ARTICLE: Astaxanthin ameliorates cardiomyocyte apoptosis after coronary microembolization by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats
    Yugang Xue
    Chuang Sun
    Qimeng Hao
    Jin Cheng
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 341 - 348
  • [7] Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway
    Lorestani, Faezeh
    Movahedian, Ahmad
    Mohammadalipour, Adel
    Hashemnia, Mohammad
    Aarabi, Mohammad Hossein
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (02) : 128 - 136
  • [8] Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway
    Lorestani, Faezeh
    Movahedian, Ahmad
    Mohammadalipour, Adel
    Hashemnia, Mohammad
    Aarabi, Mohammad Hossein
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2023,
  • [9] Hyperbaric Oxygen Upregulates Mst1 to Activate Keap1/Nrf2/HO-1 Pathway Resisting Oxidative Stress in a Rat Model of Acute Myocardial Infarction
    Liu, Jianhui
    Li, Yan
    Wu, Shubiao
    Zhang, Zhigang
    Li, Di
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (01) : 284 - 293
  • [10] The role of Keap1/Nrf2/HO-1 signal pathway in liver injury induced by rare earth neodymium oxide in mice
    卜宁
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (02) : 82 - 83